A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)
Clinical trial NCT06108219 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06108219
- Sponsor
- Corcept Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-25
- Primary completion
- 2026-09-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.